BGI Genomics Co., Ltd. (300676.SZ)
CNY 49.17
(-0.02%)
CNY 49.17
(-0.02%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 13.61 Billion CNY | -5.3% |
| 2022 | 14.37 Billion CNY | 0.85% |
| 2021 | 14.25 Billion CNY | 27.32% |
| 2020 | 11.19 Billion CNY | 89.45% |
| 2019 | 5.9 Billion CNY | 12.52% |
| 2018 | 5.25 Billion CNY | 2.73% |
| 2017 | 5.11 Billion CNY | 20.84% |
| 2016 | 4.23 Billion CNY | 8.16% |
| 2015 | 3.91 Billion CNY | 90.88% |
| 2014 | 2.04 Billion CNY | 36.83% |
| 2013 | 1.49 Billion CNY | 49.19% |
| 2012 | 1 Billion CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 13.38 Billion CNY | -0.56% |
| 2024 Q1 | 13.45 Billion CNY | -1.15% |
| 2024 Q3 | 13.28 Billion CNY | -0.72% |
| 2023 Q2 | 13.6 Billion CNY | -0.5% |
| 2023 Q4 | 13.61 Billion CNY | 1.11% |
| 2023 FY | 13.61 Billion CNY | -5.3% |
| 2023 Q1 | 13.67 Billion CNY | -4.88% |
| 2023 Q3 | 13.46 Billion CNY | -1.04% |
| 2022 Q4 | 14.37 Billion CNY | 3.55% |
| 2022 Q3 | 13.88 Billion CNY | 3.14% |
| 2022 Q2 | 13.45 Billion CNY | 0.25% |
| 2022 FY | 14.37 Billion CNY | 0.85% |
| 2022 Q1 | 13.42 Billion CNY | -5.81% |
| 2021 Q1 | 13.45 Billion CNY | 20.16% |
| 2021 Q4 | 14.25 Billion CNY | 0.01% |
| 2021 Q3 | 14.25 Billion CNY | 3.64% |
| 2021 FY | 14.25 Billion CNY | 27.32% |
| 2021 Q2 | 13.75 Billion CNY | 2.23% |
| 2020 Q4 | 11.19 Billion CNY | 2.5% |
| 2020 FY | 11.19 Billion CNY | 89.45% |
| 2020 Q1 | 7.1 Billion CNY | 20.2% |
| 2020 Q2 | 10.04 Billion CNY | 41.43% |
| 2020 Q3 | 10.92 Billion CNY | 8.73% |
| 2019 Q4 | 5.9 Billion CNY | 4.98% |
| 2019 FY | 5.9 Billion CNY | 12.52% |
| 2019 Q3 | 5.62 Billion CNY | 3.36% |
| 2019 Q2 | 5.44 Billion CNY | 2.58% |
| 2019 Q1 | 5.3 Billion CNY | 1.09% |
| 2018 Q4 | 5.25 Billion CNY | -1.32% |
| 2018 Q1 | 5.04 Billion CNY | -1.21% |
| 2018 Q2 | 5.24 Billion CNY | 3.76% |
| 2018 FY | 5.25 Billion CNY | 2.73% |
| 2018 Q3 | 5.32 Billion CNY | 1.55% |
| 2017 FY | 5.11 Billion CNY | 20.84% |
| 2017 Q3 | 4.97 Billion CNY | 15.17% |
| 2017 Q1 | 4.16 Billion CNY | -1.65% |
| 2017 Q2 | 4.31 Billion CNY | 3.78% |
| 2017 Q4 | 5.11 Billion CNY | 2.8% |
| 2016 Q1 | - CNY | -100.0% |
| 2016 Q4 | 4.23 Billion CNY | 0.0% |
| 2016 FY | 4.23 Billion CNY | 8.16% |
| 2015 Q2 | 3.64 Billion CNY | 0.0% |
| 2015 Q4 | 3.91 Billion CNY | 0.0% |
| 2015 FY | 3.91 Billion CNY | 90.88% |
| 2015 Q1 | 3.64 Billion CNY | 0.0% |
| 2014 FY | 2.04 Billion CNY | 36.83% |
| 2013 FY | 1.49 Billion CNY | 49.19% |
| 2012 FY | 1 Billion CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Dian Diagnostics Group Co.,Ltd. | 17.93 Billion CNY | 24.116% |
| Hangzhou Tigermed Consulting Co., Ltd. | 29.69 Billion CNY | 54.161% |
| Dirui Industrial Co.,Ltd. | 3.32 Billion CNY | -309.936% |
| Beijing Strong Biotechnologies, Inc. | 5.17 Billion CNY | -163.015% |
| Medicalsystem Biotechnology Co., Ltd. | 3.48 Billion CNY | -290.149% |
| Maccura Biotechnology Co.Ltd | 8.11 Billion CNY | -67.663% |
| Guangzhou Wondfo Biotech Co.,Ltd | 5.77 Billion CNY | -135.857% |
| Guangdong Hybribio Biotech Co.,Ltd. | 5.72 Billion CNY | -137.749% |
| Amoy Diagnostics Co., Ltd. | 1.93 Billion CNY | -603.558% |
| Shanghai Labway Clinical Laboratory Co., Ltd. | 2.98 Billion CNY | -355.763% |